ESTHER
CHAMORRO DE VEGA
Profesora asociada de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (12)
2023
-
Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS
Journal of medical economics, Vol. 26, Núm. 1, pp. 463-472
-
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
Open Forum Infectious Diseases, Vol. 10, Núm. 2
2022
-
Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience
Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283
-
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare
Frontiers in Immunology, Vol. 13
-
Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study
Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 12, pp. 2020-2029
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
2021
-
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
International Journal of Antimicrobial Agents, Vol. 57, Núm. 2
-
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
Expert Review of Clinical Pharmacology, Vol. 14, Núm. 2, pp. 249-260
2020
-
A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis
Medical Mycology, Vol. 58, Núm. 3, pp. 300-309
-
Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases
Oncologist, Vol. 25, Núm. 5, pp. e861-e869
-
Hepatitis C virus infection and the role of a pharmaceutical care program
American Journal of Health-System Pharmacy, Vol. 77, Núm. 6, pp. 479-486
2019
-
A case-control study of real-life experience with ceftolozane-tazobactam in patients with hematologic malignancy and pseudomonas aeruginosa infection
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 2